FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,733 | -83.1% | 21,572 | -62.1% | 0.00% | -100.0% |
Q2 2023 | $270,648 | -17.6% | 56,859 | -1.3% | 0.00% | -33.3% |
Q1 2023 | $328,304 | -73.1% | 57,597 | -52.4% | 0.00% | -72.7% |
Q4 2022 | $1,220,053 | -57.2% | 120,917 | -5.0% | 0.01% | -57.7% |
Q3 2022 | $2,851,000 | -17.8% | 127,218 | -9.1% | 0.03% | -3.7% |
Q2 2022 | $3,468,000 | -32.4% | 139,974 | +5.7% | 0.03% | -12.9% |
Q1 2022 | $5,132,000 | -44.1% | 132,375 | -15.6% | 0.03% | -35.4% |
Q4 2021 | $9,179,000 | +10.9% | 156,888 | +12.3% | 0.05% | -4.0% |
Q3 2021 | $8,278,000 | -8.4% | 139,663 | +34.1% | 0.05% | -5.7% |
Q2 2021 | $9,041,000 | +3.5% | 104,174 | -1.7% | 0.05% | -7.0% |
Q1 2021 | $8,734,000 | +3.9% | 105,930 | +14.6% | 0.06% | +7.5% |
Q4 2020 | $8,403,000 | +260.5% | 92,408 | +58.5% | 0.05% | +211.8% |
Q3 2020 | $2,331,000 | +16.0% | 58,308 | -0.4% | 0.02% | +6.2% |
Q2 2020 | $2,009,000 | +167.2% | 58,558 | +72.9% | 0.02% | +100.0% |
Q1 2020 | $752,000 | +92.3% | 33,868 | +69.6% | 0.01% | +166.7% |
Q4 2019 | $391,000 | +98.5% | 19,965 | +57.8% | 0.00% | +50.0% |
Q3 2019 | $197,000 | +358.1% | 12,653 | +19.0% | 0.00% | – |
Q3 2017 | $43,000 | +30.3% | 10,636 | +3.3% | 0.00% | – |
Q2 2017 | $33,000 | – | 10,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |